Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection

Hepatology Research

Volumn 47, Issue 2, 2017, Pages 226-233

  Ichikawa, Yuki ^a   Joshita, Satoru ^a   Umemura, Takeji ^a   Shobugawa, Yugo ^b   Usami, Yoko ^a   Shibata, Soichiro ^a   Yamazaki, Tomoo ^a   Fujimori, Naoyuki ^a   Komatsu, Michiharu ^a   Matsumoto, Akihiro ^a   Tanaka, Eiji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

hepatitis B virus; hepatocellular carcinoma; liver fibrosis; Serum Wisteria floribunda agglutinin positive human Mac 2 binding protein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BINDING PROTEIN; COLLAGEN TYPE 4; COLLAGEN TYPE 7; HYALURONIC ACID; TYPE IV COLLAGEN 7S; UNCLASSIFIED DRUG; WISTERIA FLORIBUNDA AGGLUTININ POSITIVE HUMAN MAC 2 BINDING PROTEIN;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BLOOD LEVEL; CHRONIC HEPATITIS B; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; FIBROSIS 4 INDEX; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; WISTERIA; WISTERIA FLORIBUNDA;

EID: 85011573172     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12712     Document Type: Article

References (23)

1. Custer B, Sullivan SD, Hazlet TK et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158–68.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495–500.
3. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293–302.e4.
4. Hui AY, Chan HL, Wong VW et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100: 616–23.
5. Kuno A, Ikehara Y, Tanaka Y et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 2013; 3: 1065.
6. Umemura T, Joshita S, Sekiguchi T et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol 2015; 110: 857–64.
7. Abe M, Miyake T, Kuno A et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol 2015; 50: 776–84.
8. Nishikawa H, Enomoto H, Iwata Y et al. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res 2015. doi:10.1111/hepr.12596
9. Yamasaki K, Tateyama M, Abiru S et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology 2014; 60: 1563–70.
10. Sasaki R, Yamasaki K, Abiru S et al. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response. PLoS One 2015; 10:.e0129053
11. http://www.who.int/mediacentre/factsheets/fs204/en/.
12. Umemura T, Tanaka E, Kiyosawa K, Kumada H. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis 2008; 47: e52–6.
13. Kuno A, Sato T, Shimazaki H et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl 2013; 7: 642–7.
14. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518–26.
15. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317–25.
16. Umemura T, Zen Y, Hamano H et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463–71.
17. Ichida F, Tsuji T, Omata M et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepat Comm 1996; 6: 112–9.
18. Ura K, Furusyo N, Ogawa E et al. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C. Aliment Pharmacol Ther 2016; 43: 114–24.
19. Artini M, Natoli C, Tinari N et al. Elevated serum levels of 90 K/MAC-2 BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients. J Hepatol 1996; 25: 212–7.
20. Fujiyoshi M, Kuno A, Gotoh M et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol 2015; 50: 1134–44.
21. Iacobelli S, Sismondi P, Giai M et al. Prognostic value of a novel circulating serum 90 K antigen in breast cancer. Br J Cancer 1994; 69: 172–6.
22. Iacovazzi PA, Cozzolongo R, Lanzillotta E et al. Serum 90 K/Mac-2 binding protein (Mac-2BP) as a response predictor to peginterferon and ribavirin combined treatment in HCV chronic patients. Immunopharmacol Immunotoxicol 2008; 30: 687–700.
23. Sasaki T, Brakebusch C, Engel J, Timpl R. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds β1 integrins, collagens and fibronectin. EMBO J 1998; 17: 1606–13.